You Still Have Options GLP-1s for menopause weight gain have opened up a new avenue of hope for many women, but theyre not accessible to everyone
Approved by the FDA under the name Egrifta for HIV-related lipodystrophy, it has demonstrated an increase in IGF-1, a 15.2% reduction in visceral fat, and an improvement in body composition in Phase 3 trials
Its also the target of popular weight loss medications like Ozempic and Wegovy
Her goal is to work with patients using an integrated approach combining nutrition, sleep habits, stress management and exercise to achieve better health with less medication
This creates permanent improved blood supply
In the weight-loss craze, they have teamed up with telehealth websites, which heavily market GLP-1s to consumers on social media platforms and even in TV ads